Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

AUTOR(ES)

Bakker-Woudenberg, I A

RESUMO

The importance of intact host defense mechanisms for successful antimicrobial therapy was investigated in an animal model. Recovery from lobar pneumococcal pneumonia as a result of penicillin therapy was studied in normal rats and in rats treated with cobra venom factor. This factor was used to selectively suppress the phagocytosis of pneumococci as a result of complement depletion. Although complete recovery from the infection occurred in normal rats after appropriate penicillin therapy, this was not the case in cobra venom factor-treated rats. Within the limitations of this study, evidence is presented for loss of antibiotic activity as a consequence of impaired phagocytosis.

Documentos Relacionados

• Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis.
• Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.
• Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.
• Ceforanide and cefazolin therapy of pneumonia: comparative clinical trial.
• Ventilator-associated pneumonia: the influence of bacterial resistance, prescription errors, and de-escalation of antimicrobial therapy on mortality rates